nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—TOP2A—salivary gland cancer	0.924	1	CbGaD
Amsacrine—NCOA3—Validated nuclear estrogen receptor beta network—SMARCE1—salivary gland cancer	0.0114	0.151	CbGpPWpGaD
Amsacrine—NCOA3—FOXA1 transcription factor network—NFIB—salivary gland cancer	0.00697	0.0919	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—ALKBH1—salivary gland cancer	0.00532	0.0702	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—SMARCE1—salivary gland cancer	0.00275	0.0363	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—KRT5—salivary gland cancer	0.00236	0.0312	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—KRT14—salivary gland cancer	0.0022	0.029	CbGpPWpGaD
Amsacrine—NCOA3—FOXA1 transcription factor network—BRCA1—salivary gland cancer	0.00198	0.0261	CbGpPWpGaD
Amsacrine—NCOA3—Retinoic acid receptors-mediated signaling—CREBBP—salivary gland cancer	0.00157	0.0207	CbGpPWpGaD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—BRCA1—salivary gland cancer	0.00147	0.0193	CbGpPWpGaD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—MYB—salivary gland cancer	0.00144	0.0189	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—EN1—salivary gland cancer	0.00126	0.0166	CbGpPWpGaD
Amsacrine—NCOA3—FOXA1 transcription factor network—CREBBP—salivary gland cancer	0.00116	0.0153	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—SMARCA2—salivary gland cancer	0.00114	0.0151	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—BRCA1—salivary gland cancer	0.00113	0.0148	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—salivary gland cancer	0.00109	0.0143	CbGpPWpGaD
Amsacrine—NCOA3—Retinoic acid receptors-mediated signaling—EP300—salivary gland cancer	0.00107	0.0141	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—salivary gland cancer	0.000941	0.0124	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—NSD1—salivary gland cancer	0.000924	0.0122	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—PRKDC—salivary gland cancer	0.00083	0.0109	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—CNTN6—salivary gland cancer	0.000821	0.0108	CbGpPWpGaD
Amsacrine—NCOA3—FOXA1 transcription factor network—EP300—salivary gland cancer	0.000789	0.0104	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 1—NOTCH1—salivary gland cancer	0.000782	0.0103	CbGpPWpGaD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—CREBBP—salivary gland cancer	0.00074	0.00975	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—BRCA1—salivary gland cancer	0.000738	0.00972	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—CRTC1—salivary gland cancer	0.000687	0.00906	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—CREBBP—salivary gland cancer	0.000659	0.00869	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—SMC1A—salivary gland cancer	0.000635	0.00837	CbGpPWpGaD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—CCND1—salivary gland cancer	0.000635	0.00837	CbGpPWpGaD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—EP300—salivary gland cancer	0.000584	0.0077	CbGpPWpGaD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—NOTCH1—salivary gland cancer	0.000584	0.00769	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—MC3R—salivary gland cancer	0.00056	0.00738	CbGpPWpGaD
Amsacrine—NCOA3—PPARA activates gene expression—CREBBP—salivary gland cancer	0.000556	0.00733	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—ATM—salivary gland cancer	0.000554	0.0073	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—MAP2K2—salivary gland cancer	0.000549	0.00724	CbGpPWpGaD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—salivary gland cancer	0.000544	0.00718	CbGpPWpGaD
Amsacrine—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—salivary gland cancer	0.000531	0.007	CbGpPWpGaD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—EP300—salivary gland cancer	0.000504	0.00664	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—ATM—salivary gland cancer	0.000497	0.00655	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—CCND1—salivary gland cancer	0.000488	0.00643	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—MYB—salivary gland cancer	0.000483	0.00637	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—PTEN—salivary gland cancer	0.000471	0.0062	CbGpPWpGaD
Amsacrine—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.000466	0.00614	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—EP300—salivary gland cancer	0.000449	0.00592	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—GINS2—salivary gland cancer	0.00043	0.00567	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.000429	0.00565	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PRKDC—salivary gland cancer	0.000425	0.0056	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ISYNA1—salivary gland cancer	0.000401	0.00528	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—GINS2—salivary gland cancer	0.000384	0.00507	CbGpPWpGaD
Amsacrine—NCOA3—PPARA activates gene expression—EP300—salivary gland cancer	0.000379	0.00499	CbGpPWpGaD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—salivary gland cancer	0.000375	0.00495	CbGpPWpGaD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—salivary gland cancer	0.000371	0.00489	CbGpPWpGaD
Amsacrine—TOP2A—Gastric Cancer Network 2—TP53—salivary gland cancer	0.000327	0.00432	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—MARCKS—salivary gland cancer	0.000327	0.00431	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.000319	0.00421	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—ESPL1—salivary gland cancer	0.000309	0.00407	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.000308	0.00406	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PYGB—salivary gland cancer	0.000304	0.004	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.000294	0.00388	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—PTEN—salivary gland cancer	0.000291	0.00384	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—ESPL1—salivary gland cancer	0.000276	0.00364	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—FOXO3—salivary gland cancer	0.000276	0.00364	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.000268	0.00353	CbGpPWpGaD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—salivary gland cancer	0.000256	0.00337	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.000253	0.00333	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PHGDH—salivary gland cancer	0.000248	0.00326	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ST3GAL4—salivary gland cancer	0.000238	0.00314	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MAP2K2—salivary gland cancer	0.000225	0.00297	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—salivary gland cancer	0.000218	0.00287	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AQP1—salivary gland cancer	0.000216	0.00285	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.00021	0.00277	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—NUP62—salivary gland cancer	0.000196	0.00258	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—HRAS—salivary gland cancer	0.00019	0.00251	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NOTCH1—salivary gland cancer	0.000184	0.00243	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00018	0.00238	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.000178	0.00235	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—NUP62—salivary gland cancer	0.000175	0.00231	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—NUP62—salivary gland cancer	0.000172	0.00226	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—VCAN—salivary gland cancer	0.00017	0.00224	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—CREBBP—salivary gland cancer	0.000167	0.00221	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—SMC1A—salivary gland cancer	0.000164	0.00216	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000157	0.00207	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CCND1—salivary gland cancer	0.000153	0.00202	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000149	0.00197	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—SMC1A—salivary gland cancer	0.000147	0.00193	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.000145	0.00191	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—TP53—salivary gland cancer	0.000143	0.00189	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.000121	0.0016	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.000121	0.00159	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000116	0.00153	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—BRCA1—salivary gland cancer	0.000116	0.00153	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—EP300—salivary gland cancer	0.000114	0.0015	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000112	0.00148	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00011	0.00145	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PTEN—salivary gland cancer	0.000108	0.00142	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000107	0.00141	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000107	0.00141	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—EP300—salivary gland cancer	0.000103	0.00135	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000102	0.00134	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	8.82e-05	0.00116	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	8.23e-05	0.00108	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	7.9e-05	0.00104	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—ATM—salivary gland cancer	7.81e-05	0.00103	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—HRAS—salivary gland cancer	7.8e-05	0.00103	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	7.64e-05	0.00101	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.53e-05	0.000992	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—salivary gland cancer	7.34e-05	0.000967	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	6.67e-05	0.000879	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CREBBP—salivary gland cancer	6.65e-05	0.000877	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	5.94e-05	0.000783	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ISYNA1—salivary gland cancer	5.78e-05	0.000762	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CCND1—salivary gland cancer	5.62e-05	0.000741	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	5.45e-05	0.000719	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	5.29e-05	0.000697	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—HRAS—salivary gland cancer	5.21e-05	0.000687	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—EP300—salivary gland cancer	5.17e-05	0.000682	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	5.16e-05	0.000681	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CCND1—salivary gland cancer	5.02e-05	0.000662	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTEN—salivary gland cancer	4.75e-05	0.000626	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MARCKS—salivary gland cancer	4.72e-05	0.000622	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—EP300—salivary gland cancer	4.62e-05	0.00061	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—EP300—salivary gland cancer	4.53e-05	0.000597	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MARCKS—salivary gland cancer	4.44e-05	0.000586	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PYGB—salivary gland cancer	4.38e-05	0.000578	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PYGB—salivary gland cancer	4.13e-05	0.000545	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	3.82e-05	0.000504	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	3.69e-05	0.000486	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PHGDH—salivary gland cancer	3.57e-05	0.000471	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	3.52e-05	0.000464	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	3.44e-05	0.000453	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PHGDH—salivary gland cancer	3.37e-05	0.000444	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CA—salivary gland cancer	3.35e-05	0.000442	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—salivary gland cancer	3.31e-05	0.000436	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	3.24e-05	0.000427	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AQP1—salivary gland cancer	3.12e-05	0.000412	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AQP1—salivary gland cancer	2.94e-05	0.000388	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	2.6e-05	0.000343	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	2.52e-05	0.000332	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NUP62—salivary gland cancer	2.48e-05	0.000327	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—VCAN—salivary gland cancer	2.46e-05	0.000324	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NUP62—salivary gland cancer	2.33e-05	0.000308	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—VCAN—salivary gland cancer	2.32e-05	0.000305	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	2.05e-05	0.00027	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CREBBP—salivary gland cancer	9.6e-06	0.000127	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CREBBP—salivary gland cancer	9.05e-06	0.000119	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTEN—salivary gland cancer	6.86e-06	9.04e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—EP300—salivary gland cancer	6.54e-06	8.62e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTEN—salivary gland cancer	6.46e-06	8.52e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—EP300—salivary gland cancer	6.16e-06	8.13e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CA—salivary gland cancer	4.84e-06	6.38e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	4.56e-06	6.01e-05	CbGpPWpGaD
